During the clinical manifestation of AD, a temporospatial spreading of Tau-positive neurofibrillary lesions is observed, suggesting that once Tau pathology is initiated it may spread along the axonal network and propagate between connected neuronal cells; moreover, the extent of Tau pathology strongly correlates with symptom severity and neuronal cell loss (1). Here, MAPT is linked to Alzheimer disease.